News Daily News El SLF Nobori es Similar al Promus Element en el Manejo de Lesiones Largas Jason Kahn May 30, 2014
News Conference News EuroPCR 2014 EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight Caitlin E. Cox May 28, 2014
News Conference News EuroPCR 2014 Nobori BES Demonstrates Good Long-term Outcomes with No Stent Thrombosis Beyond 3 Years Yael L. Maxwell May 23, 2014
News Industry News Elixir Medical Announces Outstanding Long-term Clinical Results at EuroPCR for World’s Broadest Portfolio of Three CE Mark-approved Novolimus Eluting Coronary Intervention Systems May 23, 2014
News Conference News EuroPCR 2014 Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions Caitlin E. Cox May 20, 2014
News Conference News EuroPCR 2014 CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device Caitlin E. Cox May 20, 2014
News Conference News ACC 2014 ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation Yael L. Maxwell April 03, 2014
Presentation ACC 2014 Two-Year Outcome of a Randomized Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer Presenter: Masahiro Natsuaki March 31, 2014
News Conference News ACC 2014 NEXT at 2 Years: Nobori DES Still Noninferior to Xience/Promus Jason Kahn March 31, 2014
Presentation CIT 2014 CREDIT I: A First-In-Man Study of the Second Generation EXCEL Biodegradable PolymerSirolimus-Eluting Stent - 4-Month Clinical, Angiographic, and OCT Results Presenter: Han Yaling March 22, 2014
News Daily News Un Stent Bioabsorbible de 1ª Generación Funciona Bien en Lesiones de la AFS Jason Kahn February 20, 2014
News Daily News First-Generation Bioresorbable Stent Performs Well in SFA Lesions Jason Kahn February 20, 2014
News Daily News DUTCH PEERS Published: Third-Generation Zotarolimus, Everolimus Stents Equivalent February 12, 2014
News Daily News DUTCH PEERS Publicado: Los Stents liberadores de Zotarolimus y Everolimus de 3ª Generación son Equivalentes February 12, 2014
News Daily News Los SLF de 1ª Generación son Menos Rentables que SMD + Rapamicina Oral a los 5 Años January 06, 2014
News Conference News TCT 2013 Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit November 03, 2013